TNFRSF10B and rheumatoid arthritis: Several observations have suggested that targeting the TNF-related apoptosis inducing ligand (TRAIL), a member of the TNF family or its death receptors TRAIL-R1 (DR4) and TRAIL-R2 (DR5) may have a therapeutic role in RA.